EDITORIAL

BioBoard

Australia
•  Well-known antibiotic amoxycillin found to be ineffective cough treatment
•  Bring the noise: has technology made us scared of silence?

India
•  Biocon receives marketing authorization for novel biologic itolizumab for psoriasis

Israel
•  Aspireo reports Somatoprim Phase Ib interim data

Japan
•  Daiichi Sankyo and Amplimmune announce strategic alliance to develop AMP-110 therapy for autoimmune disease
•  Eisai signs agreement with Epizyme and Roche Molecular Systems to develop companion diagnostic

The Philippines
•  Asia-Pacific Analysis: The growth of stem-cell therapy
•  Is the world ready for scientific diplomacy?

United Kingdom
•  ARIAD and the U.K. National Cancer Research Institute to collaborate on SPIRIT 3 clinical study
•  Vision research collaboration on novel treatment for wet age-related macular degeneration

United States
•  Reducing medical mistakes: Two recently published studies support the use of DNA testing on biopsy samples to prevent misdiagnoses
•  CoDa Therapeutics reports positive results from Phase IIb Study of NEXAGON® in chronic venous leg ulcers
•  Inovio Pharmaceuticals to initiate clinical trial for its hepatitis C therapeutic vaccine later this year
•  Jolt to brain eases pain without drugs
•  Can a new vaccine prevent colon cancer?
•  Immunovaccine’s DPX-Survivac produces sustained, dose related immune responses in Phase I ovarian cancer study

Eye on China
•  NCKU researcher develops new use of reservoir sediment
•  WILEX Inc. and GeneDiagnostics Inc. enter into partnership for the IVD approval and distribution of the serum HER-2/neu test
•  Celsion Corporation and Zhejiang Hisun Pharmaceutical Company enter into technology development agreement for ThermoDox® for the Greater China Territory
•  SFDA grants approval for clinical studies to benapenem
•  UroFlex now CE-marked; Chinese SFDA approval for Cellvizio
•  China National Genebank and Smithsonian’s National Museum of Natural History collaborate on biobanking to advance biodiversity research
•  New analytical method for uleine alkaloids having anticancer activity
•  Zhifei Biological’s vaccine approved for clinical test
•  EntreMed files new drug clinical trial application for ENMD-2076 with China SFDA to advance global development strategy

Features
•  The Biotechnology Incubation Center of Academia Sinica: A Gateway to Innovative Taiwan
•  Cancer Targeting Nanomedicine: An Opportunity for Drug Development in Asia with Emphasis on Taiwan
•  Recombinant Lipoproteins for the Development of Novel Subunit Vaccines
•  Discovery of Therapeutic Human Monoclonal Antibodies through B-cell Immortalization Technology

People Watch
•  The Crystal Ball on Biosimilars with Dr. Anthony Rebuck

Inside Industry
•  Cognoptix licenses AD detection technology
•  3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement
•  Medicago is awarded contract from the U.S. Department of Defence for potential future production
•  Clinical Network Services (CNS) acquires New Zealand partner BELTAS’ business assets
•  VABIOTECH licenses cell-based Japanese encephalitis technology from Inviragen
•  University of Illinois licenses novel anti-cancer therapies to StemPar Sciences
•  Adimab announces new discovery collaboration with Kyowa Hakko Kirin
•  Priaxon enters collaboration with GSK on protein-protein-interactions
•  Lantheus Medical Imaging and FUJIFILM RI Pharma renew long-term license and distribution agreement for Cardiolite and Neurolite in Japan

•  Conference Calendar